NM_007217.4:c.557+4_557+7delAGTA
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_007217.4(PDCD10):c.557+4_557+7delAGTA variant causes a splice region, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_007217.4 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- cerebral cavernous malformation 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- famililal cerebral cavernous malformationsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cerebral cavernous malformation 3 Pathogenic:3
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with cerebral cavernous malformations-3 (MIM#603285). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0209 - Splice site variant suggested to affect splicing of the transcript with uncertain effect on protein sequence. Abnormal splicing of exon 8 (also annotated as exon 9 in previous literature), leading to a frameshift and a change in the position of stop codon has been described following cDNA analysis; however, the relevant data was not shown by the authors (PMID: 15543491). This abnormal splicing is not expected to result in nonsense-mediated decay (NMD). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0705 - No comparable splice site variants have previous evidence for pathogenicity. (I) 0803 - This variant has limited previous evidence of pathogenicity in unrelated individuals. This variant has been reported in ClinVar once as pathogenic and once as de novo in an individual with cerebral cavernous malformations (PMID: 15543491). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1102 - Strong phenotype match for this individual. (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
This sequence change falls in intron 7 of the PDCD10 gene. It does not directly change the encoded amino acid sequence of the PDCD10 protein, but it affects a nucleotide within the consensus splice site of the intron. For these reasons, this variant has been classified as Pathogenic. Nucleotide substitutions within the consensus splice site are relatively common causes of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of nucleotide changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. Furthermore, cDNA analysis of the individual reported in PMID: 15543491 reported abnormal PDCD10 mRNA splicing. This variant has been shown to arise de novo in an individual affected with cerebral cavernous malformation (PMID: 15543491). This variant is also known as c.556_557+2del4 in the literature. This variant is not present in population databases (ExAC no frequency). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at